Nxera Pharma Co (TSE:4565) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4565 Nxera Pharma Co Ltd TSE:4565
68 GF Score
Price 円921.00
GF Value 円1,348.94
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co FFO per Share?

FFO per Share only applies to REITs.

TSE:4565
68GF Score
Nxera Pharma Co Ltd TSE:4565
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of 円921.00 is trading 31.7% below its estimated GF Value™ of 円1,348.94. GuruFocus considers Nxera Pharma Co to be Possible Value Trap.

Key valuation signals for TSE:4565:

  • FFO per Share:
  • GF Value™: 円1,348.94 vs. price of 円921.00 (31.7% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
68GF Score

Get the complete analysis for TSE:4565

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円921.00
Price
円1,348.94
GF Value